These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1906030)

  • 21. Effects of general anaesthesia on portal venous pressure in the rat.
    Belghiti J; Blanchet L; Lebrec D
    Eur Surg Res; 1981; 13(4):285-9. PubMed ID: 7285995
    [No Abstract]   [Full Text] [Related]  

  • 22. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
    Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
    J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
    Tripathi DM; Erice E; Lafoz E; García-Calderó H; Sarin SK; Bosch J; Gracia-Sancho J; García-Pagán JC
    Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G301-9. PubMed ID: 26138461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organic nitrates in portal hypertension.
    Blei AT; Ganger D; Fung HL; Groszmann R
    Eur Heart J; 1988 Jan; 9 Suppl A():205-11. PubMed ID: 3137068
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute hemodynamic effects of nitroglycerin in pulmonary hypertension.
    Pearl RG; Rosenthal MH; Schroeder JS; Ashton JP
    Ann Intern Med; 1983 Jul; 99(1):9-13. PubMed ID: 6407380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological vs. mechanical reduction in portal pressure: a comparative study.
    Groszmann RJ; Blei AT; Storer EH; Conn HO
    Surgery; 1978 Nov; 84(5):679-85. PubMed ID: 715683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intravenous nitroglycerin and metoclopramide on intravariceal pressure: a double-blind, randomized study.
    Saraya A; Sarin SK
    Am J Gastroenterol; 1993 Nov; 88(11):1850-3. PubMed ID: 8237931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats.
    Cummings SA; Groszmann RJ; Kaumann AJ
    Br J Pharmacol; 1986 Nov; 89(3):501-13. PubMed ID: 3801785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of isoproterenol on the systemic circulation of a dog with cardiopulmonary bypass].
    Hagemann K; Niehues B; Manoli SH; Arnold G; Lochner W
    Z Kardiol; 1974 Jun; 63(6):542-9. PubMed ID: 4212639
    [No Abstract]   [Full Text] [Related]  

  • 31. [Stresses in portal venous system of pre-hepatic portal hypertension (PHT) rabbits].
    Zhang Z; Tang S; Zhu L; Wu G; Jiang Z; Shi B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1322-6. PubMed ID: 19166202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New aspects of the mode of action of nitroglycerin: changes in the wave-resistance of arteries close to the heart].
    Martin KL; Böhmer H; Röckemann W; Kaltenbach M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1123-6. PubMed ID: 829458
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of calcium-channel blockers in cirrhotic patients with portal hypertension].
    Li D
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):370-4, 26. PubMed ID: 2171726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis.
    Koshy A; Hadengue A; Lee SS; Jiron MI; Lebrec D
    Clin Pharmacol Ther; 1987 Sep; 42(3):295-8. PubMed ID: 3621783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propranolol--a medical treatment for portal hypertension?
    Lebrec D; Nouel O; Corbic M; Benhamou JP
    Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of portal vascular resistance in patients with portal hypertension.
    Moriyasu F; Nishida O; Ban N; Nakamura T; Miura K; Sakai M; Miyake T; Uchino H
    Gastroenterology; 1986 Mar; 90(3):710-7. PubMed ID: 2935445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestration.
    Packer M
    Am Heart J; 1985 Jul; 110(1 Pt 2):259-64. PubMed ID: 3925745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse effect of dopamine on portal venous pressure.
    Kibbey W; Sirinek KR; Thomford NR; Pace WG
    Rev Surg; 1977; 34(3):202-5. PubMed ID: 866979
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of 2-camphanone on canine portal vein blood flow and rat smooth muscle.
    Xie JM; Greenberg SS; Longenecker G
    Gastroenterology; 1992 Feb; 102(2):394-402. PubMed ID: 1732110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nitroglycerin and dipyridamole on regional coronary resistance.
    Fam WM; McGregor M
    Circ Res; 1968 May; 22(5):649-59. PubMed ID: 4967491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.